Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Start-Up Adapts Crispr for Molecular Detection, Raises $40M

Crispr graphic

A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler. . . . → Read More: Start-Up Adapts Crispr for Molecular Detection, Raises $40M

Streamlined Gene Therapy Delivery Process Demonstrated

Sickle cells illustration

A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive. . . . → Read More: Streamlined Gene Therapy Delivery Process Demonstrated

Bio-Friendly Plant Nutrient Delivery Patent Awarded

Seedlings in soil

A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded

Patent Issued for Synthetic Peptide Chain Techniques

U.S. Patent and Trademark Office

A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques

Infographic – Chinese Companies Lead in A.I. Patents

Chart: A.I. patents by company, 2017 and 2021

Data in the chart are compiled by PatentSight, a service of LexisNexis, that show the seven leading holders of machine learning and other A.I. patents by company in 2017 and 2021. . . . → Read More: Infographic – Chinese Companies Lead in A.I. Patents

Patent Awarded for Focused Ultrasound Skin Treatments

U.S. Patent and Trademark Office

A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology. . . . → Read More: Patent Awarded for Focused Ultrasound Skin Treatments

Patent Issued for Crispr-Edited Viruses in Microbiome

Crispr-Cas9

A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome

Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Brewer's yeast

A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Patent Issued for Anti-Bacterial Viruses with Crispr Payloads

Crispr graphic

A biotechnology company received a patent for its engineered viruses to deliver gene-edited treatments to combat bacterial infections in the microbiome. . . . → Read More: Patent Issued for Anti-Bacterial Viruses with Crispr Payloads

Patent Board Rules for Broad Inst. in Crispr Case

Crispr graphic

A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells. . . . → Read More: Patent Board Rules for Broad Inst. in Crispr Case